Document is current
Any future updates will be listed below
-
Authors
Geerling, Clara F. https://orcid.org/0000-0001-9733-3458
Terheyden, Jan H. https://orcid.org/0000-0002-0174-4066
Langner, S. Magdalena
Kindler, Christine
Keil, Vera C.
Turski, Christopher A.
Turski, Gabrielle N.
Wintergerst, Maximillian W. M.
Petzold, Gabor C.
Finger, Robert P.
-
Funding
Funding for this research was provided by:
Rheinische Friedrich-Wilhelms-Universität Bonn
- License Information
-
More Information
Article History
Received: 17 June 2021
Accepted: 21 February 2022
First Online: 7 March 2022
Competing interests
: CFG, JHT, SML, CAT, GNT: Heidelberg Engineering, Optos, Carl Zeiss Meditec, CenterVue (devices). CK, VCK: none. MWMW: Heidelberg Engineering, Optos, Carl Zeiss Meditec, CenterVue (devices), DigiSight Technologies (travel support) Heine Optotechnik (research funding), Heine Optotechnik (research funding, devices, travel reimbursement, consultant), D-EYE Srl (devices), Eyenuk Inc. (free analysis), ASKIN & CO GmbH (travel reimbursement, honoraria), Berlin-Chemie AG (grant, travel reimbursements). GCP: Bayer, Boehringer, Pfizer und BMS (sponsoring). RPF: Bayer, Novartis, Santen, Opthea, Novelion, Santhera, Inositec, Alimera and RetinaImplant, Allergan, Boehringer Ingelheim (consultant); Bayer, Ellex, Alimera (research funding); Heidelberg Engineering, Optos, Carl Zeiss Meditec, CenterVue (devices).
